Publications
Reed J; Kanamarlapudi V; Bain S. Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists. Cardiovascular Endocrinology. Publish Ahead of Print():, DEC 2017. DOI: 10.1097/XCE.0000000000000147. Issn Print: 2162-688X
Dasgupta I, Banerjee D, Chowdhury TA, De P, Wahba M, Bain S, Frankel A, Fogarty D, Pokrajac A, Winocour PH. Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease. British Journal of Diabetes. 17(4), 160-164. DOI: https://doi.org/10.15277/bjd.2017.152
Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V; CREDENCE study investigators. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics. Am J Nephrol. 2017 Dec 13;46(6):462-472. doi: 10.1159/000484633. [Epub ahead of print] PMID: 29253846
Swindell N, Mackintosh K, McNarry M, Stephens JW, Sluik D, Fogelholm M, Drummen M, MacDonald I, Martinez JA, Handjieva-Darlenska T, Poppitt SD, Brand-Miller J, Larsen TM, Raben A, Stratton G. Objectively Measured Physical Activity and Sedentary Time Are Associated With Cardiometabolic Risk Factors in Adults With Prediabetes: The PREVIEW Study. Diabetes Care. 2017 Nov 20. pii: dc171057. doi: 10.2337/dc17-1057. [Epub ahead of print] PMID: 29158249
Min T, Davies GI, Rice S, Chess J, Stephens JW. Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset. Diabetes Metab Syndr. 2017 Nov 23. pii: S1871-4021(17)30353-3. doi: 10.1016/j.dsx.2017.11.002. [Epub ahead of print] PMID: 29239764
Thomas NE, Rowe DA, Murtagh EM, Stephens JW, Williams R. Associations between metabolic syndrome components and markers of inflammation in Welsh school children. Eur J Pediatr. 2017 Dec 22. doi: 10.1007/s00431-017-3065-y. [Epub ahead of print] PMID: 29273941
Asderakis A, Khalid U, Madden S, Dayan C. The Influence of Socioeconomic Deprivation on Outcomes in Pancreas Transplantation in England; Registry Data Analysis. Am J Transplant. 2017 Dec 23. doi: 10.1111/ajt.14633. [Epub ahead of print] PMID: 29275542
Moser O, Yardley JE, Bracken RM. Interstitial Glucose and Physical Exercise in Type 1 Diabetes: Integrative Physiology, Technology, and the Gap In-Between. Nutrients. 2018 Jan 15;10(1). pii: E93. doi: 10.3390/nu10010093. Review. PMID: 29342932
Monnier L, Colette C, Owens D. Glucose variability: Do we have to revisit the profusion of definitions to avoid confusion? Diabetes Metab. 2017 Nov 16. pii: S1262-3636(17)30545-1. doi: 10.1016/j.diabet.2017.10.005. [Epub ahead of print] No abstract available. PMID: 29153486
Vilsbøll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simó R, Helmark IC, Wijayasinghe N, Larsen M. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2017 Nov 27. doi: 10.1111/dom.13172. [Epub ahead of print] PMID: 29178519